canadian cardiovascular society: Live & Latest News Updates : Vimarsana.com

Coronary Sinus Reducer an Option for Intractable Angina?

A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.

Updated guidelines in Canada to assess private and commercial drivers' fitness to drive

Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

Shockwave Medical has positive Reducer data

Shockwave Medical (Nasdaq:SWAV) announced positive six-month real-world outcomes for its Reducer technology.

Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory AnginaSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results

Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study -April 08, 2024 at 04:03 pm EDT

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina SANTA CLARA, Calif., April 08, 2024 -- Shockwave Medical, Inc. , a pioneer...

Shockwave Medical (SWAV) Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study

Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina

After ORBITA-COSMIC, Reducer device's mechanism of benefit remains unknown

Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study

SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercializati...

Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study